INfluenza Vaccine to Effectively Stop Cardio Thoracic Events & Decompensated heart failure (INVESTED)
PI(s): Scott Solomon, Harvard Medical School; Orly Vardeny, University of Wisconsin - Madison
Project Summary: INVESTED assessed whether high-dose influenza vaccine compared with standard dose vaccine will reduce cardiopulmonary events in a high-risk cardiovascular population. The study found that the high-dose vaccine was not more effective to reduce death or cardiopulmonary hospitalizations among high cardiovascular risk patients.
Study Design: Multi-CRN Interventional Study
Coordinating Center: University of Wisconsin-Madison; Harvard Medical School; University of Toronto; Clinical Sciences Center, Madison, Wisconsin